(PharmaNewsWire.Com, December 21, 2017 ) The North America Coronary Stent Market was worth USD 2.5 billion in 2016 and estimated to be growing at a CAGR of 7.3%, to reach USD 3.56 billion by 2021. A stent is a metal or plastic tube inserted into the lumen of an anatomic vessel or duct to keep the passageway open, and stenting is the placement of a stent. There is a wide variety of stents used for different purposes, from expandable coronary, vascular and biliary stents, to simple plastic stents used to allow the flow of urine between kidney and bladder.
Major factors driving the growth of this market include technological advancements, increasing number of coronary related procedures, increasing demand for minimally invasive procedures, and rising geriatric population. Moreover, development of bioresorbable vascular scaffold (BVS) and expansion in emerging markets provide significant growth opportunities in the market provide significant growth opportunities in the market. However, alternative treatment methods for CAD, stringent regulations for product approval, and numerous cases of product failure and product recall may hinder the growth of this market during the forecast period.
The market for Coronary Stent is broadly categorized into type, mode of delivery, material type and End user. By type, the market is further segmented into bare metal stents, drug eluting stemts and bioabsorbable stents. The market is expected to be driven by bioresorbable stents, mainly in the polylactic acid material. However, drug eluting stents will continue to generate major revenue. By mode of delivery, it is further classified into balloon expandable stents and self-expanding stents. By material, market is analysed under metallic stents and other stents. By end user, the market is divided into hospitals, cardiac centres and ambulatory surgical centres. On the basis of geography, the global market is analysed under various regions namely U.S.A and Canada. North America is dominating the global market. U.S.A is accounting for a major share in the regional market.
Market Segmentation: • Type • Mode of delivery • Material • End user
Key players in this market include Medtronic plc (Ireland), Abbott Laboratories (U.S.), Boston Scientific Corporation (U.S.), Biosensors International Group, Ltd. (Singapore), BIOTRONIK SE & Co. KG (Germany), B. Braun Melsungen AG (Germany), TERUMO CORPORATION (Japan), STENTYS SA (France), MicroPort Scientific Corporation (China), Meril Life Sciences Pvt. Ltd. (India), Vascular Concepts (India), and Translumina GmbH (Germany). <||>rnhttps://www.marketdataforecast.com/cart/buy-now/north-america-coronary-stent-market-2699/ About Market Data Forecast:
The publisher of this report is Market Data Forecast whose forte lies in Market research and Business Intelligence. Handling both individual and corporate clients across multiple business domains they offer syndicated/customized research to suit the client’s research objective. Their research reports section offers a wide variety of market studies ranging from all-encompassing comprehensive market studies to product specific niche markets covering North America among other regions of the global market as well. For more info kindly visit, www.marketdataforecast.com
Contact: Abhishek Shukla Sales Manager (International Business Development) Market Data Forecast Direct Line: +1-888-702-9626 Mobile: +91 998 555 0206 Mail: abhishek@marketdataforecast.com Visit MarketDataForecast Blog @ http://www.marketdataforecast.com/blog/
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Biotechnology & Pharmaceuticals resource center today to browse our selection of 600+ complimentary Biotechnology & Pharmaceuticals magazines, white papers, webinars, podcasts, and more. Get popular titles including:
